Home
Poseida Therapeutics

Poseida Therapeutics Market Share Analysis for February 2026

Poseida Therapeutics is a clinical-stage biopharmaceutical company developing cell and gene therapies with the capacity to cure cancers and genetic diseases.

Health > Biotechnology and Pharmaceuticals

Domainposeida.com

Year Founded2014

Employees201 - 500

Annual Revenue$100M - $200M

Poseida Therapeutics

Poseida Therapeutics (including company regionals)

poseida.com

See more website traffic and engagement information

Poseida Therapeutics Revenue up to February 2026 is 100M - 200M

revenue generated by Poseida Therapeutics top domains

Poseida Therapeutics top domains revenue over 3 years

Revenue for Poseida Therapeutics top domains

poseida.com100M - 200M

See more with Sales Intelligence

Total visits to Poseida Therapeutics's top domains

Understand Poseida Therapeutics market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

poseida.com5.5K

See more with Sales Intelligence

Avg. visit duration in Poseida Therapeutics's top domains

Analyze Poseida Therapeutics engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

poseida.com00:01:02

See more with Sales Intelligence

Avg. pageviews on Poseida Therapeutics's top domains

See how Poseida Therapeutics keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

poseida.com2.10

See more with Sales Intelligence

Poseida Therapeutics top competitors by domain

Top similar sites in February 2026, ranked by their affinity

daiichisankyo.comCompany NameDaiichi SankyoEmployees> 10001HQJapan, TokyoAnnual revenue> $1BTotal visits164.3KHealth > Biotechnology and Pharmaceuticals

Top technologies used by Poseida Therapeutics

These are the website technologies, by industry, used by Poseida Therapeutics top domains

Advertising (5)

DoubleClick

Conversion & Analytics (4)

Google Analytics

Widget (4)

Twemoji

Mobile (2)

Meta Viewport

More Technologies

9

See all

News & Signals from Poseida Therapeutics

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsBasbaum leaves Poseida Therapeutics, Inc. as Senior Vice President of Business Development.Prior to joining MBX Biosciences, Ms. Basbaum served as Senior Vice President of Business Development at Poseida Therapeutics, where she was a member of the Executive Committee and led strategic partnerships and corporate transactions totaling more than $10 billion in potential value, and she played a key role in the company's sale to Roche for up to $1.5 billion.

NewsPoseida Therapeutics, Inc. is developing CAR-T programmes for solid tumours and autoimmune diseases.Poseida is also working on CAR-T programmes for solid tumours and autoimmune diseases.

NewsRoche acquired Poseida Therapeutics, Inc. for $1.5B on Nov 26th '24.Poseida (Nasdaq: PSTX) announced Nov. 26 that it had entered into a merger agreement to be acquired by Roche (OTCMKTS: RHHBY) in a transaction worth up to $1.5 billion.